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Background and Purpose: Different mutations in the Cu/Zn superoxide dismutase 1 (SOD1) gene have been 
reported in approximately 10% of cases of familial amyotrophic lateral sclerosis (ALS). The aim of this study was 
to analyze for mutations in the SOD1 gene and clinical characteristics in Korean family of ALS.
Methods: A subpopulation of the family reported here has been described previously. In the present study, we 
analyzed the SOD1 gene in the proband and his immediate family members, who were not reported on previously. 
Genomic DNA was isolated from the leukocytes of whole blood samples and the coding region of the SOD1 gene 
was analyzed by PCR and direct sequencing.
Results: The genetic alterations were a GGC-to-GTT transition at codon 10 in exon 1 and [IVS4+15_16insA; 
IVS4+42delG; IVS4+59_60insT] in intron 4. Patients with these mutations exhibit diverse clinical onset symptoms and 
acceleration of the age at onset in successive generations, which is called anticipation. 
Conclusions: We have described a family with familial ALS that showed autosomal-dominant inheritance and two 
distinct genetic alterations in Cu/Zn-SOD1. The affected family members had different phenotypes and anticipation. 
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is an adult-onset 
neurodegenerative disorder characterized by the death of 
motor neurons in the cerebral cortex, brainstem, and 
spinal cord. ALS occurs in both familial and sporadic 
forms.
1 Familial ALS (FALS) represents 5–10% of ALS 
cases, and is usually expressed as an autosomal- 
dominant trait that is clinically indistinguishable from 
sporadic cases. Many such familial cases have been 
reported to be associated with mutations in the gene that 
codes for Cu/Zn superoxide dismutase (SOD1).
2,3
More than 122 mutations of the SOD1  gene have 
been reported in FALS and sporadic ALS patients,
4  the 
vast majority of which are point mutations (single-base- 
pair substitutions) that are widely distributed within the 
gene, through exons 1–5. It is well known that the sites Kim WJ, et al. Korean Familial Amyotrophic Lateral Sclerosis with Superoxide Dismutase 1 Gene Mutation 
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Figure 1. Pedigree of the family. Squares represent males and circles represent females. Filled symbols represent 
those affected with ALS. Oblique lines represent deceased family members. The arrow indicates the proband.
Each mark represents the result of genetic testing as follows:
*indicates carriers of the heterozygous G10V mutation plus intronic alterations of the SOD1 gene.
†indicates an individual who tested positive for the intronic alterations alone. 
‡indicates individuals who showed normal sequences of the SOD1 gene. 
§indicates an individual who has been previously described as being positive for the G10V mutation.
15
and types of mutations associated with ALS are not 
correlated with clinical findings such as age at onset and 
duration of illness.
5 A few frameshift and nonsense 
mutations have also been reported in cases of FALS as 
well as sporadic ALS,
6–13  and have been found pre-
dominantly in exon 4, intron 4, and exon 5.
14
A subpopulation of the family reported here has been 
described previously.
15  However, since the proband and 
his immediate family were not included in the previous 
report, in this study we analyzed the SOD1 gene in this 
family group, and found genetic alterations in exon 1 
and intron 4 that have not been previously described. 
PATIENTS AND METHODS
1. Patients
The pedigree of the family is shown in Figure 1. 
After obtaining their informed consent, we studied 6 
family members from a 4-generation pedigree with 16 
members affected by FALS. The proband in this study 
(individual IV-6), a 37-year-old male, was admitted 
to a hospital in July 2002 with rapidly progressing 
hoarseness and subjective weakness in all four limbs 
(he died 7 months later). We were able to obtain 
information on the family pedigree. The age at onset of 
disease was designated as the first sign of weakness, 
atrophy, or clinical symptoms involving upper- or lower- 
motor neurons. ALS was diagnosed using the El 
Escorial criteria as suggested by the World Federation of 
Neurology Research Group on Neuromuscular dis-
orders.
16 The information pertaining to family members 
for whom no clinical records were available was 
obtained from other family members; this information 
was useful for fully understanding the modality of 
genetic transmission.
The study was approved by the local ethics co-
mmittee, and all patients gave their written informed 
consent for participation.
2. Molecular genetic analysis
The presence of SOD1 mutations was analyzed in the 
affected proband and five family members. Genomic 
DNA was isolated from blood leukocytes obtained from 
each individual using the QIAamp DNA Blood Mini Kit 
(QIAGEN, CA, USA). The region encoding the five Journal of Clinical Neurology: Vol. 3, No. 1, 2007
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Table 1. Age at disease onset and disease duration in parent and offspring generations (mean±SD values)
　 Age at disease onset (years)　　 Disease duration (months)　
Generation Males (n=11) Females (n=5) Total 　 Males (n=11) Females (n=5) Total
II 52.7±4.7 - 52.7±4.7 14.4±3.6 - 14.4±3.6
III 43.0±2.8 47.5±0.7 45.3±3.1 18.0±8.4 13.2±1.2 15.6±6.0
IV 29.7±7.6 39.0±2.6 32.8±7.7 　 13.2±6.0 15.6±3.6 13.2±4.8
exons of the SOD1 gene were amplified from genomic 
DNA with the polymerase chain reaction (PCR) using 
previously described primers.
11 The reactions were per-
formed in 5 μl volumes, and included 100 ng of tem-
plate (genomic DNA), each primer at 10 pmol/μl, 2.5 
mM dNTP, and 1 U of Taq polymerase (Perkin-Elmer, 
MA, USA) in the buffer with MgCl2. PCR amplification 
was performed using 30 cycles of 1 min at 94℃, 45 sec 
at 60℃, and 1 min at 72℃. The resulting PCR products 
were sequenced using the ABI Prism BigDye terminator 
cycle sequencing Ready Reaction kit (PE Applied Bio-
systems, CA, USA) and forward and reverse primers 
used in the PCR amplification. The sequencing reaction 
was performed with the ABI 3700 automated sequencer 
(PE Applied Biosystems). The data were collected and 
analyzed using ABI DNA sequence analysis software 
(version 3.6).
RESULTS
1. Clinical findings
The proband (IV-6), a right-handed 37-year-old male, 
is identified by the black arrow on Figure 1. He first 
noticed hoarseness and subjective weakness in all limbs 
at 36 years of age. A standard medical workup did not 
reveal any abnormalities. A neurological examination 
showed mild weakness of all four limbs with muscular 
atrophy and hyperactive deep tendon reflexes. Bulbar 
symptoms such as dysarthria, dysphagia, and tongue 
fasciculations were also present.
His motor and sensory nerve conduction velocities 
were normal. Electromyography revealed increased inser-
tional activity, as well as active denervation discharges 
in three paraspinal regions (cervical, thoracic, and lumbo-
sacral), and fasciculation potentials in all limbs.
2. Family analysis
The pedigree consisted of 35 members, distributed 
throughout 4 generations. Sixteen affected members 
were identified: three patients on the basis of anamnestic 
data (probable disease), five patients that have been 
previously reported,
15 and eight patients after review of 
the available medical records (cases of diagnosed disease). 
There were no skipped generations.
The pedigree revealed the presence of autosomal- 
dominant transmission. The age at onset was 39.3±10.6 
years (mean±SD; range, 20 to 58 years) in diagnosed 
family members with probable disease (ages at onset 
were 52.7±4.7, 45.3±3.1, and 32.8±7.7 years in gene-
rations II, III, and IV, respectively; p<0.01 by Kruskal- 
Wallis test) (Table 1). However, the duration of disease 
symptoms (14.7±5.3 months; range, 7–24 months) did 
not differ among individuals from this pedigree. The 
initial clinical symptoms varied among the family 
members (Table 2). In contrast to the previous report 
(on individuals III-19, -20, -21, and -23),
15 the proband 
(III-6) and his elder sister (III-5) showed bulbar 
symptoms including hoarseness, swallowing difficulty, 
and respiratory difficulty.
3. Molecular genetic analysis
DNA analysis of the proband (IV-6) revealed the 
presence of a heterozygous GGC-to-GTT mutation 
resulting in a substitution of valine for glycine at codon 
10 in exon 1 and non-amino-acid-altering variations 
[IVS4+15_16insA; IVS4+42delG; IVS4+59_60insT] in 
intron 4 of the SOD1 gene (Fig. 2). The same changes 
were also detected in two sisters (IV-5 and IV-7). The Kim WJ, et al. Korean Familial Amyotrophic Lateral Sclerosis with Superoxide Dismutase 1 Gene Mutation 
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Figure 2. Automated sequence analysis of exon 
1 and intron 4 from the SOD1 gene showing the 
heterozygous G10V mutation and intronic altera-
tions, respectively. The panel shows a GGC-to- 
GTT transition (arrow) that resulted in the sub-
stitution of valine for glycine (A) and non-amino- 
acid-altering variations [IVS4+15_16insA; IVS4+ 
42delG; IVS4+59_60insT] in intron 4 (B).
Green lines; adenine residues (A), blue lines; 
cytosine (C), black lines; guanine (G), red lines; 
thymine (T).
intronic alterations alone were found in the proband’s 
brother (IV-8).
DISCUSSION
In the present study, we identified exonic mutation 
and intronic alterations in the SOD1 gene in a Korean 
family with FALS. Patients with these mutations have 
differing clinical onset symptoms and anticipation (i.e., 
acceleration of the age at onset in successive gene-
rations).
The subpopulation of this family reported on pre-
viously, who had only G10V mutations, showed mostly 
lower motor neuron involvement, ascending progression, 
and rapid disease progression.
15 However, as a whole, 
SOD1  mutations in this family resulted in different 
phenotypes, although anticipation was a unique feature, 
especially in the males. The observed anticipation may 
have been influenced by observer bias given that (1) the 
deduction of clinical onset in generation II based on 
anamnestic data can cause overinterpretation and (2) 
other (younger) family members who were not affected 
at the time of this study may develop the disease later. 
Mutation testing in all unaffected family members is 
necessary to completely resolve this issue, but ethical 
issues make this difficult. Further follow-up is warranted 
in at least one younger sister (IV-7) in the family who 
had a mutation of the SOD1 gene and was alive without 
any symptoms.
Anticipation has been reported in several FALS 
families,
17–19  but its molecular basis remains speculative. 
It has been suggested that anticipation can result from 
additional genetic effects or from environmental factors.
4 
An amino acid substitution at position 84 in Japanese 
and Italian families was found to be associated with 
generational anticipation, which might also have been 
associated with several factors such as being male and 
exposure to toxicants.
17,18 The presence of a G93S mu-
tation in another Japanese family suggests that ethnicity 
influences this genetic mutation.
19  The G10V mutation 
was reported to occur exclusively in Korea, whereas 
other synonymous glycine
10 mutations were found in 
other ethnic groups.
12 Therefore, factors that generate 
anticipation in our family may be related to an ethnic–
genetic interaction in addition to the effect of being 
male, although the role of the particular codon mutation 
itself cannot be excluded. 
In our family, the pathogenic role of the intronic 
variations in the SOD1 gene remains unclear. With few 
exceptions, mutations in the SOD1  gene destabilize the 
structure of the SOD1 protein through metal-ion loss or 
perturbations of protein folding, and these destabilized 
SOD1 proteins either aggregate or turn over more Kim WJ, et al. Korean Familial Amyotrophic Lateral Sclerosis with Superoxide Dismutase 1 Gene Mutation 
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rapidly relative to the wild-type enzyme.
20 The proband 
and his elder sister (carrying mutations in the exons and 
introns of the SOD1 gene) showed clinical symptoms 
that differed from those of previously reported family 
members, especially at the initial stage of the disease.
15 
One possible explanation for the phenotypic differences 
and anticipation is intronic changes to the G10V muta-
tion having an cumulative effect over generations. It is 
also possible that the intronic alterations of the SOD1 
gene contribute to the manifestations of FALS in other 
ways, such as by altering the pattern of gene expression 
by disturbing RNA splicing, or causing conformation 
changes of the gene product. However, since we did not 
functionally analyze the SOD1 enzyme activity or SOD1 
at the protein level, further investigations are needed to 
elucidate the role of the intronic variations. In addition, 
it cannot be ruled out that these intronic variations 
represent a simple single-nucleotide polymorphism in the 
Korean population. Additional studies in a larger sample 
are required for confirmation.  
In summary, we have described a family with FALS 
that showed autosomal-dominant inheritance and two 
distinct genetic alterations in Cu/Zn-SOD1, in which the 
affected family members exhibited different phenotypes 
and anticipation.  
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